A strong ESG-profile, and patented processes coupled with world class R&D with diversified pipelines including research programs on asthma, COVID-19 and gastro
Download our latest report, or view all quarterly and yearly reports in the archives.
Half-yearly Report
26.08.2022
Quarterly Report Q1
06.05.2022
Quarterly Report Q3
11.11.2022
Quarterly Report Q4
10.02.2023
Download our latest investor presentation in PDF-format for a even deeper insight into our current ongoing business and future potential.